ConductScience.org, home

Trial · NCT05378646

Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDynamics of the total score and improvement in the quality of life on the scale IPSS.Day 13
The sum of points was assessed, as well as the symptom complex on the basis of the "IPSS" questionnaire - the international system for the total assessment of symptoms of prostate diseases in points (WHO, 1992). The severity of symptoms was assessed from 0 to 6 points. symptoms of prostate diseases in points (WHO, 1992). The severity of symptoms is rated from 0 to 6 points.
PrimaryImmunohistochemical study of prostate secretion with assessment of cytological parameters.Day 14Content of polymorphonuclear leukocytes in prostate secretion.
PrimaryImmunohistochemical study of prostate secretion with assessment of cytological parameters.Day 14The content of lymphocytes in prostate secretion.
PrimaryEvaluation of cytological parameters of prostate secretion.Day 14The number of lecithin grains.
PrimaryEvaluation of cytological parameters of prostate secretion.Day 14The number of epithelial cells.
PrimaryMicroscopy of prostate secretion and immunohistochemical study of prostate secretion with assessment of cytological parameters.Day 14The effect of interferon-gamma on T-lymphocytes.
PrimaryEvaluation of cytological parameters of prostate secretion.Day 90The content of polymorphonuclear leukocytes in prostate secretion.
PrimaryImmunohistochemical study of prostate secretion with assessment of cytological parameters.Day 90The content of lymphocytes in prostate secretion.
PrimaryEvaluation of cytological parameters of prostate secretion.Day 90The number of lecithin grains.
PrimaryEvaluation of cytological parameters of prostate secretion.Day 90The number of epithelial cells.
PrimaryMicroscopy of prostate secretion and immunohistochemical study of prostate secretion with assessment of cytological parameters.Day 90The effect of interferon-gamma on T-lymphocytes.
PrimaryEvaluation of indicators of urination. Ultrasound of the prostate gland.Day 90Ultrasound of the prostate gland.
PrimaryEvaluation of indicators of urination. Urofluometry.Day 90Urofluometry.
PrimaryEvaluation of indicators of urination. General urine analysis.Day 90General urine analysis.
PrimaryEvaluation of the inter-relapse period. Identification of an exacerbation of a chronic process.Month 3Percentage of patients with exacerbation of chronic prostatitis and signs of disease recurrence during the follow-up period.
PrimaryEvaluation of the inter-relapse period. Identification of signs of a relapse of the disease.Month 3Percentage of patients with exacerbation of chronic prostatitis and signs of disease recurrence during the follow-up period.
PrimaryEvaluation of the inter-relapse period. Identification of an exacerbation of a chronic process.Month 6Percentage of patients with exacerbation of chronic prostatitis and signs of disease recurrence during the follow-up period.
PrimaryEvaluation of the inter-relapse period. Identification of signs of a relapse of the disease.Month 6Percentage of patients with exacerbation of chronic prostatitis and signs of disease recurrence during the follow-up period.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05378646/registered